Opaleye Management Inc. Macrogenics Inc Transaction History

Opaleye Management Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.25 - $9.99 $378,225 - $1.68 Million	-168,100 Reduced 44.66%	208,300 $614,000
Q1 2022 May 16, 2022	SELL	$8.12 - $16.9 $695,071 - $1.45 Million	-85,600 Reduced 18.53%	376,400 $3.32 Million
Q3 2021 Nov 16, 2021	SELL	$19.74 - $28.7 $2.29 Million - $3.33 Million	-116,150 Reduced 20.09%	462,000 $9.67 Million
Q2 2021 Aug 16, 2021	SELL	$20.49 - $35.63 $1.8 Million - $3.14 Million	-88,050 Reduced 13.22%	578,150 $15.5 Million
Q1 2021 May 18, 2021	BUY	$18.99 - $33.2 $5.61 Million - $9.81 Million	295,600 Added 79.76%	666,200 $21.2 Million
Q4 2020 Feb 12, 2021	SELL	$19.41 - $26.0 $3.04 Million - $4.07 Million	-156,400 Reduced 29.68%	370,600 $8.47 Million
Q3 2020 Nov 16, 2020	BUY	$24.69 - $31.6 $641,940 - $821,600	26,000 Added 5.19%	527,000 $13.3 Million
Q2 2020 Aug 14, 2020	BUY	$5.2 - $29.12 $409,240 - $2.29 Million	78,700 Added 18.64%	501,000 $14 Million
Q1 2020 May 15, 2020	BUY	$4.28 - $12.11 $949,304 - $2.69 Million	221,800 Added 110.62%	422,300 $2.46 Million
Q4 2019 Feb 14, 2020	BUY	$7.95 - $12.27 $1.59 Million - $2.46 Million	200,500 New	200,500 $2.18 Million
Q1 2019 May 15, 2019	SELL	$11.11 - $25.6 $1.67 Million - $3.84 Million	-150,000 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$11.75 - $21.42 $1.76 Million - $3.21 Million	150,000 New	150,000 $1.91 Million

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.